401 related articles for article (PubMed ID: 19013074)
1. Studies on quinones. Part 44: Novel angucyclinone N-heterocyclic analogues endowed with antitumoral activity.
Valderrama JA; Colonelli P; Vásquez D; González MF; Rodríguez JA; Theoduloz C
Bioorg Med Chem; 2008 Dec; 16(24):10172-81. PubMed ID: 19013074
[TBL] [Abstract][Full Text] [Related]
2. Studies on quinones. Part 41: synthesis and cytotoxicity of isoquinoline-containing polycyclic quinones.
Valderrama JA; González MF; Pessoa-Mahana D; Tapia RA; Fillion H; Pautet F; Rodriguez JA; Theoduloz C; Schmeda-Hirschmann G
Bioorg Med Chem; 2006 Jul; 14(14):5003-11. PubMed ID: 16563773
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and cytotoxic effect of hydroxy- and 3-alkylaminopropoxy-9,10-anthraquinone derivatives.
Teng CH; Won SJ; Lin CN
Bioorg Med Chem; 2005 May; 13(10):3439-45. PubMed ID: 15848756
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, human telomerase inhibition and anti-proliferative studies of a series of 2,7-bis-substituted amido-anthraquinone derivatives.
Huang HS; Huang KF; Li CL; Huang YY; Chiang YH; Huang FC; Lin JJ
Bioorg Med Chem; 2008 Jul; 16(14):6976-86. PubMed ID: 18571928
[TBL] [Abstract][Full Text] [Related]
5. Studies on quinones. Part 47. Synthesis of novel phenylaminophenanthridinequinones as potential antitumor agents.
Valderrama JA; Ibacache A; Rodriguez JA; Theoduloz C; Benites J
Eur J Med Chem; 2011 Aug; 46(8):3398-409. PubMed ID: 21621882
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antitumor activity of 6- and 2-(1-substituted-thio-4-methylpent-3-enyl)-5,8-dimethoxynaphthalene-1,4-diones.
Zhao LM; Xie TP; He YQ; Xu DF; Li SS
Eur J Med Chem; 2009 Apr; 44(4):1410-4. PubMed ID: 18996624
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of 9,10-anthraquinone monoalkylaminoalkylhydrazones as potential antitumor drugs.
Antonini I; Polucci P; Cola D; Palmieri G; Martelli S; Bontemps-Gracz M
Farmaco; 1993 Dec; 48(12):1641-8. PubMed ID: 8135988
[TBL] [Abstract][Full Text] [Related]
8. Studies on quinones. Part 45: novel 7-aminoisoquinoline-5,8-quinone derivatives with antitumor properties on cancer cell lines.
Valderrama JA; Ibacache JA; Arancibia V; Rodriguez J; Theoduloz C
Bioorg Med Chem; 2009 Apr; 17(7):2894-901. PubMed ID: 19269832
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of novel bis-anthraquinone derivatives and their biological evaluation as antitumor agents.
Taher AT; Hegazy GH
Arch Pharm Res; 2013 May; 36(5):573-8. PubMed ID: 23471561
[TBL] [Abstract][Full Text] [Related]
10. Activation of human telomerase reverse transcriptase expression by some new symmetrical bis-substituted derivatives of the anthraquinone.
Huang HS; Chiou JF; Fong Y; Hou CC; Lu YC; Wang JY; Shih JW; Pan YR; Lin JJ
J Med Chem; 2003 Jul; 46(15):3300-7. PubMed ID: 12852760
[TBL] [Abstract][Full Text] [Related]
11. Studies on quinones. Part 42: Synthesis of furylquinone and hydroquinones with antiproliferative activity against human tumor cell lines.
Benites J; Valderrama JA; Rivera F; Rojo L; Campos N; Pedro M; José Nascimento MS
Bioorg Med Chem; 2008 Jan; 16(2):862-8. PubMed ID: 17964791
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and in vitro antitumor activity of new 1,4-diarylimidazole-2-ones and their 2-thione analogues.
Congiu C; Cocco MT; Onnis V
Bioorg Med Chem Lett; 2008 Feb; 18(3):989-93. PubMed ID: 18164978
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and cytotoxic activity of a new series of topoisomerase I inhibitors.
Dallavalle S; Gattinoni S; Mazzini S; Scaglioni L; Merlini L; Tinelli S; Beretta GL; Zunino F
Bioorg Med Chem Lett; 2008 Feb; 18(4):1484-9. PubMed ID: 18248813
[TBL] [Abstract][Full Text] [Related]
14. Syntheses of novel heterocycles as anticancer agents.
Chauhan PM; Martins CJ; Horwell DC
Bioorg Med Chem; 2005 May; 13(10):3513-8. PubMed ID: 15848764
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, DNA binding, and cytotoxicity studies of pyrrolo[2,1-c][1,4]benzodiazepine-anthraquinone conjugates.
Kamal A; Ramu R; Tekumalla V; Khanna GB; Barkume MS; Juvekar AS; Zingde SM
Bioorg Med Chem; 2007 Nov; 15(22):6868-75. PubMed ID: 17822905
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antitumoral activity of novel 3-(2-substituted-1,3,4-oxadiazol-5-yl) and 3-(5-substituted-1,2,4-triazol-3-yl) beta-carboline derivatives.
Formagio AS; Tonin LT; Foglio MA; Madjarof C; de Carvalho JE; da Costa WF; Cardoso FP; Sarragiotto MH
Bioorg Med Chem; 2008 Nov; 16(22):9660-7. PubMed ID: 18951806
[TBL] [Abstract][Full Text] [Related]
17. 1,4,9,10-Anthradiquinone as precursor for antitumor compounds.
Schenck LW; Kuna K; Frank W; Albert A; Asche C; Kucklaender U
Bioorg Med Chem; 2006 May; 14(10):3599-614. PubMed ID: 16458517
[TBL] [Abstract][Full Text] [Related]
18. Studies on quinones. Part 46. Synthesis and in vitro antitumor evaluation of aminopyrimidoisoquinolinequinones.
Vásquez D; Rodríguez JA; Theoduloz C; Calderon PB; Valderrama JA
Eur J Med Chem; 2010 Nov; 45(11):5234-42. PubMed ID: 20828890
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and in-vitro cytotoxicity evaluation of novel naphtindolizinedione derivatives, part II: improved activity for aza-analogues.
Defant A; Guella G; Mancini I
Arch Pharm (Weinheim); 2009 Feb; 342(2):80-6. PubMed ID: 19173337
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and in vitro cytotoxic activity of aza- and diazaanthraquinone derivatives.
Nebois P; do Nascimento SC; Boitard M; Bartoli MH; Fillion H
Pharmazie; 1994 Nov; 49(11):819-21. PubMed ID: 7838868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
